CN203506819U - Visible balloon cannula for esophageal and gastric varices - Google Patents
Visible balloon cannula for esophageal and gastric varices Download PDFInfo
- Publication number
- CN203506819U CN203506819U CN201320663151.6U CN201320663151U CN203506819U CN 203506819 U CN203506819 U CN 203506819U CN 201320663151 U CN201320663151 U CN 201320663151U CN 203506819 U CN203506819 U CN 203506819U
- Authority
- CN
- China
- Prior art keywords
- gas charging
- cannula
- balloon
- gas
- sleeve pipe
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Abstract
The utility model discloses a visible balloon cannula for esophageal and gastric varices. The visible balloon cannula comprises a cannula, a gas charging tube I, a gas charging connector I, a gas charging connector II and a gas charging tube II. One end of the cannula is connected with a handheld end, and a therapeutic window is arranged at the other end of the cannula; a distal balloon is arranged on one side of the therapeutic window, and a proximal balloon is arranged on the other side of the therapeutic window; the gas charging tube I and the gas charging tube II are respectively arranged on two sides of the inner wall of the cannula; one end of the gas charging tube I is connected with the distal balloon, and the other end of the gas charging tube I is connected with the gas charging connector I; one end of the gas charging tube II is connected with the proximal balloon, and the other end of the gas charging tube II is connected with the gas charging connector II. The visible balloon cannula has the advantages that a hemorrhage point of a patient can be accurately compressed by the aid of the cannula and one balloon until hemorrhage is stopped under endoscopic control; the esophageal wall of the patient can be compressed by the other balloon, so that the ascending veins of the patient can be occluded, and the probability of ectopic embolization can be reduced; the visible balloon cannula can bring convenience for doctors of most primary hospitals to skillfully master tissue glue injection and sclerotherapy injection technologies, and the intraoperative safety can be improved.
Description
Technical field
This utility model relates to medical instruments field, is a kind of visual sacculus sleeve pipe of esophagus fundus ventricularis varication specifically.
Background technology
Esophagus, it is the anxious critical illness that threatens health of people that gastric varices [1] breaks hemorrhage, especially outstanding in China, previously report that first blood mortality rate is up to 48%～62% (average 50%), as do not carried out prophylactic treatment after general medicine hemostatic treatment, the Recurrent Bleeding rate of the 2nd year improves esophageal varices bleeding treatment success rate up to interventional therapy under 70%. scopes of in recent years carrying out greatly, extended this type of patient's 5 years and 10 years survival rates. 16 the regional 19Jia hospital retrospective surveys in the whole nation esophagus gastric varices hemorrhage inpatient 1079 examples of breaking in year January in January, 2005 to 2006, total success rate of hemostasis is 89.8%, mortality rate is 10.1%, the hemostatic treatment success rate that esophagus and stomach variceal bleeding is described obviously improves, and hemostasis be take medical treatment as main. under esophageal varicosis scope, the main method of interventional therapy has: injection of sclerosing agent treatment under scope, ligation treatment and scope undertissue adhesive injection etc., above-mentioned three kinds of Therapeutic Method respectively have its pluses and minuses, if organically combined according to the state of an illness, will play more effective effect.
Simultaneously, China is hepatitis (B-mode or the third type) district occurred frequently, in crowd, hepatitis B virus carriers just reaches 1/10 according to the literature, expectation is more than 100,000,000, therefore posthepatitic cirrhosis, hepatocarcinoma become one of China's commonly encountered diseases, and the modal complication of this disease, are also that the most serious main cause of death is esophagus, the Therapy for Gastric Variceal Bleeding that portal hypertension causes.This disease for the treatment of has three kinds of methods at present, wherein therapeutic endoscopy is relatively simple to operate, few intercurrent disease, repeatable strong, emergency treatment gross hemostasis rate is high, therefore reached common understanding using it as this sick prefered method in the whole world, this technology comprises ligation treatment, three kinds of methods of sclerotherapy [2] and Histoacryl injection, wherein ligation treatment is simple to operate, few intercurrent disease, but for diameter, be less than 5mm or be greater than 10mm person and must select sclerotherapy, varices of fundus of stomach person must select Histoacryl injection treatment, no matter but Histoacryl injection or harden injection, danger is all higher, also higher to operator's specification requirement.
In sclerotherapy, likely cause original hemorrhage increase the weight of or stopped hemorrhage hemorrhage again, sclerosis simultaneously and likely enter the important organs such as lung, brain along esophagus communicating branch such as intravenous and cause dystopy thromboembolism, threat to life.The principle of sclerotherapy for being injected sclerosing agent (aethoxysklerol) in cirso-and made its generation bland necrosis, ulcer, fibrous connective tissue hypertrophy stop up vein by endoscopic injection pin under scope.When its operation easier is to inject, sclerosing agent solidifies to lag behind and causes pinprick hemorrhage, when needle point not yet thrusts vein sometimes owing to breathing, feeling sick, the reason injection deviation such as singultus even scratches vein and causes massive hemorrhage.Can be with other internal organs of the up arrival of communicating branch (as perforating veins) of expansion during some patients were injection of sclerosing agent, especially lung, brain etc., cause dystopy thromboembolism, this is also one of lethal complication of this treatment, requires operator need possess abundant endoscopic technic experience simultaneously.
[1] esophagus fundus ventricularis varication is one of the most common and the most serious complication of Cirrhotic Portal Hypertension, by gastroscope or x-ray, finds, clinical manifestation is even threat to life of massive hemorrhage of gastrointestinal tract.
[2] sclerotherapy: sclerosing agent (aethoxysklerol etc.) is injected in cirso-and forms thrombosis to stop up a kind for the treatment of technology of hemorrhage blood vessel by gastroscope.
Utility model content
In sum, the purpose of this utility model is to provide a kind of visual sacculus sleeve pipe of esophagus fundus ventricularis varication.
The purpose of this utility model realizes by following technology:
A visual sacculus sleeve pipe for esophagus fundus ventricularis varication, comprises sleeve pipe, gas tube I, gas-charging connection I, gas-charging connection II, gas tube II, and one end of sleeve pipe connects handheld terminal, and the other end is provided with treatment window; One side for the treatment of window is provided with distal balloon catheter, and opposite side is provided with proximal balloon; Internal surface of sleeve pipe both sides are respectively equipped with gas tube I and gas tube II; Gas tube I one end connects distal balloon catheter, and the other end connects gas-charging connection I; One end of gas tube II connects proximal balloon, and the other end connects gas-charging connection II.
In above-mentioned gas-charging connection I and gas-charging connection II, be provided with inlet non return check valve.
Sleeve pipe using method:
1. after the target vein of scope location, insert sleeve pipe, revoling tube enters in treatment window target vein, and other compression of vein.
2. by syringe, connect gas-charging connection, by pushing, by the proximal balloon gas injection expansion of the distal balloon catheter for the treatment of window one side and opposite side, sleeve pipe is fixed in esophagus, proximal balloon is oppressed proximal venal simultaneously, local in order to be arrested in target vein, increase curative effect, reduce sclerosing agent simultaneously and along communicating branch, go upward to other internal organs and cause dystopy thromboembolism; Block near-end target vein simultaneously and make its part in observation window more full full, be conducive to accomplish as far as possible intravenous injection.
3. after Endoscopic injection sclerotherapy, by syringe, bleed, loosen sacculus, the sleeve pipe of pulling back, aims at distal balloon catheter after injection point, and inflation, can realize hemostasis by compression.
4. again push and revoling tube, select another place's target vein to repeat above-mentioned steps, every varicose is all subject to sclerotherapy to arrive therapeutic purposes.
5. when cardia, varices of fundus of stomach injection of tissue glue, in advance sleeve pipe is placed in to lower esophageal, inflated compressing reflux veins, may in order to what reduce that tissue glue causes dystopy thromboembolism.
Being set with of window for the treatment of is beneficial to direct view under endoscope injection of sclerosing agent.
The setting of two sacculus can realize the hemostasis of direct-view lower compression, is beneficial to again and reduces dystopy thromboembolism.
Nontoxic, transparent sleeve pipe, is double-layer tube wall structure, can be to sacculus gas injection in vitro, and it can be design standard by all scopes that internal diameter size be take, all common scopes are former thereby limited because of caliber not.
Advantage of the present utility model and beneficial effect:
1, this utility model makes simple to operate by the sleeve pipe of particular design.
2, this utility model is accurately oppressed petechia until scope bleed bottom stops by sleeve pipe and sacculus.
3, another balloon compression esophageal wall of this utility model, with row vein in shutoff, reduces the probability of dystopy thromboembolism.
4, this utility model can be used for most of basic hospitals, can help doctor skillfully to grasp Histoacryl injection and sclerosis injection technique, improves the safety in operation.
Accompanying drawing explanation
Fig. 1 is structural representation of the present utility model.
In figure: 1-distal balloon catheter 2-proximal balloon 3-sleeve pipe 4-gas tube I 5-gas-charging connection I 6-inlet non return check valve 7-handheld terminal 8-gas-charging connection II 9-gas tube II 10-treats window
The specific embodiment
Below in conjunction with accompanying drawing, this utility model is described further:
As shown in Figure 1, a kind of visual sacculus sleeve pipe of esophagus fundus ventricularis varication, comprises sleeve pipe 3, gas tube I 4, gas-charging connection I 5, gas-charging connection II 8, gas tube II 9, and one end of sleeve pipe 3 connects handheld terminal 7, and the other end is provided with treatment window 10; One side for the treatment of window is provided with distal balloon catheter 1, and opposite side is provided with proximal balloon 2; Sleeve pipe 3 inwall both sides are respectively equipped with gas tube I 4 and gas tube II 9; Gas tube I 4 one end connect distal balloon catheter 1, and the other end connects gas-charging connection I 5; One end of gas tube II 9 connects proximal balloon 2, and the other end connects gas-charging connection II 8.
In gas-charging connection I 5 and gas-charging connection II 8, be provided with inlet non return check valve 7.
Embodiment
The sleeve pipe 3 inserting along scope itself has nontoxic, transparent, soft characteristic, end of term end is with a treatment window 10, a sacculus is respectively installed at its two ends, be respectively distal balloon catheter 1 and proximal balloon 2, treatment window 10 can make the target vein segment of varicose enter in sleeve pipe 3, is conducive to entry needle and thrusts accurately, completely intravenous at direct view under endoscope.
The inflation when injection of the distal balloon catheter 1 for the treatment of window 10 1 sides, can fixed sleeving 3, has guaranteed that surgical field of view is clear, be conducive to reduce breathe, feel sick, vomiting, singultus etc. cause injection site deviation; After injection finishes, can be used for oppressing injection site, avoid pinprick hemorrhage.
Claims (2)
1. the visual sacculus sleeve pipe of an esophagus fundus ventricularis varication, comprise sleeve pipe (3), gas tube I (4), gas-charging connection I (5), gas-charging connection II (8), gas tube II (9), it is characterized in that: one end of sleeve pipe (3) connects handheld terminal (7), the other end is provided with treatment window (10); One side for the treatment of window (10) is provided with distal balloon catheter (1), and opposite side is provided with proximal balloon (2); Sleeve pipe (3) inwall both sides are respectively equipped with gas tube I (4) and gas tube II (9); Gas tube I (4) one end connects distal balloon catheter (1), and the other end connects gas-charging connection I (5); One end of gas tube II (9) connects proximal balloon (2), and the other end connects gas-charging connection II (8).
2. the visual sacculus sleeve pipe of a kind of esophagus fundus ventricularis varication as claimed in claim 1, is characterized in that: in described gas-charging connection I (5) and gas-charging connection II (8), be provided with inlet non return check valve (7).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201320663151.6U CN203506819U (en) | 2013-10-26 | 2013-10-26 | Visible balloon cannula for esophageal and gastric varices |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201320663151.6U CN203506819U (en) | 2013-10-26 | 2013-10-26 | Visible balloon cannula for esophageal and gastric varices |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN203506819U true CN203506819U (en) | 2014-04-02 |
Family
ID=50365808
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201320663151.6U Expired - Fee Related CN203506819U (en) | 2013-10-26 | 2013-10-26 | Visible balloon cannula for esophageal and gastric varices |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN203506819U (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103494629A (en) * | 2013-10-26 | 2014-01-08 | 刘雄昌 | Visible sacculus sleeve for esophageal and gastric varices |
| CN104224271A (en) * | 2014-09-11 | 2014-12-24 | 中国人民解放军第三军医大学第二附属医院 | Hemostatic balloon cannula for fiberoptic bronchoscopic biopsy |
| CN106691365A (en) * | 2016-12-29 | 2017-05-24 | 天津恒宇医疗科技有限公司 | Double-balloon OCT imaging catheter |
-
2013
- 2013-10-26 CN CN201320663151.6U patent/CN203506819U/en not_active Expired - Fee Related
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103494629A (en) * | 2013-10-26 | 2014-01-08 | 刘雄昌 | Visible sacculus sleeve for esophageal and gastric varices |
| CN104224271A (en) * | 2014-09-11 | 2014-12-24 | 中国人民解放军第三军医大学第二附属医院 | Hemostatic balloon cannula for fiberoptic bronchoscopic biopsy |
| CN106691365A (en) * | 2016-12-29 | 2017-05-24 | 天津恒宇医疗科技有限公司 | Double-balloon OCT imaging catheter |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN2933337Y (en) | Arteria covering membrane supporter capable of positioning release accurately and its conveyor | |
| JP2009544397A (en) | Myoma therapy device and method | |
| CN203506819U (en) | Visible balloon cannula for esophageal and gastric varices | |
| Gupta et al. | Anaesthesia for robotic gynaecological surgery | |
| CN103494629A (en) | Visible sacculus sleeve for esophageal and gastric varices | |
| CN103654992B (en) | Cow LDA operation reset device by pressing push needle | |
| De Takáts et al. | The impairment of circulation in the varicose extremity | |
| CN102551819B (en) | Blood vessel puncture plugging sheath with balloon | |
| CN105496480A (en) | Blood vessel puncture site closer and operation method thereof | |
| CN103767754A (en) | Visible postpartum hemostasis instrument and manufacturing method thereof | |
| CN103316416B (en) | Ball head guide wire | |
| CN204972453U (en) | Portable double cannula that drips | |
| CN107432759A (en) | Sacculus hemostasis expander | |
| CN203001601U (en) | Injection device used under medical endoscope | |
| CN107454833A (en) | For port to be introduced into umbilical blood vessels and the port is maintained at the device in umbilical blood vessels | |
| CN105581822A (en) | CIT multi-endoscope combined stone extraction techniques with gallbladder preserved | |
| CN215425333U (en) | Intravascular stent propelling catheter and vascular repair system | |
| CN205391140U (en) | Blood vessel puncture mouthful shutter | |
| CN104524686A (en) | Method for treating esophageal variceal bleeding through sclerosis therapy | |
| RU2617108C1 (en) | Method for primary sclerogenic preventive hemostasis at esophagus and stomach varicose veins bleeding height | |
| CN204542253U (en) | A kind of abdominal content containment device | |
| CN203789975U (en) | Visible postpartum haemostatic instrument | |
| CN210330644U (en) | Hemostatic device | |
| CN209060133U (en) | Minimally invasive balloon drainage-tube | |
| CN214966190U (en) | Puncture hemostat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140402 Termination date: 20151026 |
|
| EXPY | Termination of patent right or utility model |